Nu Skin Enterprises, Inc. (BMV:NUS)
Mexico · Delayed Price · Currency is MXN 142.80
-1.20 (-0.83%)
At close: May 22, 2025
Silk Road Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 100.83 | -146.59 | 8.6 | 104.78 | 147.27 | 191.36 | Upgrade |
Depreciation & Amortization | 61.03 | 69.81 | 69.22 | 72.51 | 76.32 | 73.99 | Upgrade |
Loss (Gain) From Sale of Assets | -175.87 | -0.08 | 0.78 | 0.03 | 13.03 | 3.21 | Upgrade |
Asset Writedown & Restructuring Costs | 58.83 | 181.07 | 1.7 | 9.92 | 31.89 | - | Upgrade |
Loss (Gain) From Sale of Investments | 28.08 | - | - | - | -18.08 | - | Upgrade |
Stock-Based Compensation | 22.06 | 14.82 | 15.65 | 12.37 | 23.19 | 24.06 | Upgrade |
Other Operating Activities | 17.05 | 21.05 | 104.38 | 44.42 | 92.88 | 33.96 | Upgrade |
Change in Accounts Receivable | -17.82 | -7.76 | -22.68 | -11.45 | 20.22 | -11.21 | Upgrade |
Change in Inventory | 18.29 | 30.32 | -13.22 | -2.97 | -126.62 | -31.14 | Upgrade |
Change in Accounts Payable | -8.01 | -7.29 | -10.08 | 9.26 | -13.28 | 24.84 | Upgrade |
Change in Other Net Operating Assets | -11.08 | -43.6 | -35.7 | -130.8 | -105.24 | 70.07 | Upgrade |
Operating Cash Flow | 93.4 | 111.74 | 118.64 | 108.06 | 141.58 | 379.14 | Upgrade |
Operating Cash Flow Growth | -41.52% | -5.81% | 9.79% | -23.67% | -62.66% | 113.08% | Upgrade |
Capital Expenditures | -34.78 | -41.58 | -58.49 | -59.06 | -68.62 | -63.82 | Upgrade |
Cash Acquisitions | - | - | -77.28 | - | -18.96 | -14.95 | Upgrade |
Investment in Securities | 11.22 | 3.62 | 1.26 | -8.02 | -1.15 | -0.66 | Upgrade |
Investing Cash Flow | 170.17 | -37.96 | -134.5 | -67.08 | -88.73 | -79.43 | Upgrade |
Long-Term Debt Issued | - | 15 | 110 | 460 | 155 | 115 | Upgrade |
Long-Term Debt Repaid | - | -127.89 | -13.2 | -434.42 | -116.87 | -143.21 | Upgrade |
Net Debt Issued (Repaid) | -212.45 | -112.89 | 96.8 | 25.58 | 38.13 | -28.21 | Upgrade |
Issuance of Common Stock | - | - | 4.56 | 27.05 | 13.86 | 5.76 | Upgrade |
Repurchase of Common Stock | -6.27 | -2.06 | -13.01 | -70.05 | -80.42 | -144.33 | Upgrade |
Common Dividends Paid | -11.93 | -11.93 | -77.62 | -77.02 | -76.27 | -78.39 | Upgrade |
Other Financing Activities | 1.21 | -6.3 | - | -5.08 | - | - | Upgrade |
Financing Cash Flow | -229.43 | -133.18 | 10.73 | -99.5 | -104.7 | -245.17 | Upgrade |
Foreign Exchange Rate Adjustments | 5.77 | -9.78 | -3.54 | -16.35 | -11.24 | 12.51 | Upgrade |
Net Cash Flow | 39.91 | -69.17 | -8.67 | -74.87 | -63.09 | 67.05 | Upgrade |
Free Cash Flow | 58.62 | 70.16 | 60.15 | 49.01 | 72.97 | 315.32 | Upgrade |
Free Cash Flow Growth | -45.23% | 16.64% | 22.74% | -32.84% | -76.86% | 181.88% | Upgrade |
Free Cash Flow Margin | 3.60% | 4.05% | 3.06% | 2.20% | 2.71% | 12.21% | Upgrade |
Free Cash Flow Per Share | 1.18 | 1.41 | 1.21 | 0.97 | 1.42 | 5.98 | Upgrade |
Cash Interest Paid | 35.3 | 35.3 | 33.3 | 14.5 | 8.6 | 11.2 | Upgrade |
Cash Income Tax Paid | 30.4 | 30.4 | 32.4 | 42.1 | 96 | 56.2 | Upgrade |
Levered Free Cash Flow | 175.51 | 140.2 | 117.35 | 95.26 | 53.25 | 313.81 | Upgrade |
Unlevered Free Cash Flow | 186.87 | 156.71 | 133.32 | 103.69 | 60.12 | 321.99 | Upgrade |
Change in Working Capital | -18.61 | -28.34 | -81.68 | -135.96 | -224.92 | 52.56 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.